Bhasin B, Ürekli HM, Atta MG (2015) Primary and secondary hyperoxaluria: understanding the enigma. World J Nephrol 4(2):235–244. https://doi.org/10.5527/wjn.v4.i2.235

Article  PubMed  PubMed Central  Google Scholar 

Daudon M, Letavernier E, Frochot V, Haymann JP, Bazin D, Jungers P (2016) Respective influence of calcium and oxalate urine concentration on the formation of calcium oxalate monohydrate or dihydrate crystals. C R Chim 19(11–12):1504–1513. https://doi.org/10.1016/j.crci.2016.08.009

Article  CAS  Google Scholar 

Hueppelshaeuser R, von Unruh GE, Habbig S, Beck BB, Buderus S, Hesse A, Hoppe B (2012) Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn’s disease. Pediatr Nephrol 27(7):1103–1109. https://doi.org/10.1007/s00467-012-2126-8

Article  PubMed  Google Scholar 

Khan SR, Canales BK, Dominguez-Gutierrez PR (2021) Randall’s plaque and calcium oxalate stone formation: role for immunity and inflammation. Nat Rev Nephrol 17(6):417–433. https://doi.org/10.1038/s41581-020-00392-1

Article  CAS  PubMed  Google Scholar 

Miller AW, Penniston KL, Fitzpatrick K et al (2022) Mechanisms of the intestinal and urinary microbiome in kidney stone disease. Nat Rev Urol 19(12):695–707. https://doi.org/10.1038/s41585-022-00647-5

Article  PubMed  PubMed Central  Google Scholar 

Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59(1):270–276. https://doi.org/10.1046/j.1523-1755.2001.00488.x

Article  CAS  PubMed  Google Scholar 

Massey LK (2007) Food oxalate: factors affecting measurement, biological variation, and bioavailability. J Am Diet Assoc 107(7):1191–1196. https://doi.org/10.1016/j.jada.2007.04.007

Article  PubMed  Google Scholar 

Noonan SC, Savage GP (1999) Oxalate content of foods and its effect on humans. Asia Pac J Clin Nutr 8(1):64–74

Article  CAS  PubMed  Google Scholar 

Hennessey DB, Kinnear N, Rice G, Curry D, Woolsey S, Duggan B (2019) Compliance in patients with dietary hyperoxaluria: a cohort study and systematic review. Asian J Urol 6(2):200–207. https://doi.org/10.1016/j.ajur.2018.03.002

Article  PubMed  Google Scholar 

Voss S, Hesse A, Zimmermann DJ, Sauerbruch T, von Unruh GE (2006) Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test. J Urol 175(5):1711–1715. https://doi.org/10.1016/S0022-5347(05)01001-3

Article  CAS  PubMed  Google Scholar 

Hesse A, Schneeberger W, Engfeld S, Von Unruh GE, Sauerbruch T (1999) Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate. J Am Soc Nephrol 10(Suppl 14):S329–S333

CAS  PubMed  Google Scholar 

Asplin JR (2016) The management of patients with enteric hyperoxaluria. Urolithiasis 44(1):33–43. https://doi.org/10.1007/s00240-015-0846-5

Article  CAS  PubMed  Google Scholar 

Crivelli JJ, Mitchell T, Knight J, Wood KD, Assimos DG, Holmes RP, Fargue S (2020) Contribution of dietary oxalate and oxalate precursors to urinary oxalate excretion. Nutrients 13(1):62. https://doi.org/10.3390/nu13010062

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nayagam JR, Rajan R (2021) Calcium oxalate crystals as raw food antinutrient: a review. J Pharm Res Int 33(41B):295–301. https://doi.org/10.9734/jpri/2021/v33i41B32368

Article  Google Scholar 

Sorensen MD (2014) Calcium intake and urinary stone disease. Transl Androl Urol 3(3):235–240. https://doi.org/10.3978/j.issn.2223-4683.2014.06.05

Article  PubMed  PubMed Central  Google Scholar 

Attalla K, De S, Monga M (2014) Oxalate content of food: a tangled web. Urology 84(3):555–560. https://doi.org/10.1016/j.urology.2014.03.053

Article  PubMed  Google Scholar 

Hatch M, Gjymishka A, Salido EC, Allison MJ, Freel RW (2011) Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter. Am J Physiol 300(3):G461–G469. https://doi.org/10.1152/ajpgi.00434.2010

Article  CAS  Google Scholar 

Hatch M, Freel RW (2013) A human strain of Oxalobacter (HC-1) promotes enteric oxalate secretion in the small intestine of mice and reduces urinary oxalate excretion. Urolithiasis 41(5):379–384. https://doi.org/10.1007/s00240-013-0601-8

Article  CAS  PubMed  Google Scholar 

Hoppe B, Niaudet P, Salomon R et al (2017) A randomized Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. Pediatr Nephrol 32(5):781–790. https://doi.org/10.1007/s00467-016-3553-8

Article  PubMed  Google Scholar 

Ariceta G, Collard L, Abroug S et al (2023) ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria. Pediatr Nephrol 38(2):403–415. https://doi.org/10.1007/s00467-022-05591-5

Article  PubMed  Google Scholar 

Lubkowicz D, Horvath NG, James MJ et al (2022) An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria. Mol Syst Biol 18(3):e10539. https://doi.org/10.15252/msb.202110539

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shenoy BC, Cachero TG, Shin J, et al. (2012) Crystallized oxalate decarboxylase and methods of use, Patent No.: US 8142775 B2.

Koziolek M, Grimm M, Becker D et al (2015) Investigation of ph and temperature profiles in the GI tract of fasted human subjects using the Intellicap(®) system. J Pharm Sci 104(9):2855–2863. https://doi.org/10.1002/jps.24274

Article  CAS  PubMed  Google Scholar 

Cowley H, Yan Q, Koetzner L, Dolan L, Nordwald E, Cowley AB (2017) In vitro and in vivo safety evaluation of Nephure™. Regul Toxicol Pharmacol 86:241–252. https://doi.org/10.1016/j.yrtph.2017.03.016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quintero E, Bird VY, Liu H, Stevens G, Ryan AS, Buzzerd S, Klimberg IW (2020) A prospective, double-blind, randomized, placebo-controlled, crossover study using an orally administered oxalate decarboxylase (OxDC). Kidney360 1(11):1284–1290. https://doi.org/10.3467/KID.0001522020

Article  PubMed  PubMed Central  Google Scholar 

Wang W, Wang XF, Liu YH, et al. (2023) Recombinant oxalate decarboxylase expressed in filamentous fungi, US-11613745-B2

Tanner A, Bowater L, Fairhurst SA, Bornemann S (2001) Oxalate decarboxylase requires manganese and dioxygen for activity Overexpression and characterization of Bacillus subtilis YvrK and YoaN. J Biol Chem 276(47):43627–43634. https://doi.org/10.1074/jbc.M107202200

Article  CAS  PubMed  Google Scholar 

Hautmann RE (1993) The stomach: a new and powerful oxalate absorption site in man. J Urol 149(6):1401–1404. https://doi.org/10.1016/s0022-5347(17)36400-5

Article  CAS  PubMed  Google Scholar 

Chen Z, Ye Z, Zeng L, Yang W (2003) Clinical investigation on gastric oxalate absorption. Chin Med J 116(11):1749–1751

CAS  PubMed  Google Scholar 

Jaeger P, Robertson WG (2004) Role of dietary intake and intestinal absorption of oxalate in calcium stone formation. Nephron Physiol 98(2):64-p71. https://doi.org/10.1159/000080266

Article  CAS  Google Scholar 

Kararli TT (1995) Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos 16(5):351–380. https://doi.org/10.1002/bdd.2510160502

Article  CAS  PubMed